Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 81-87, 2001;
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bathum, L.
Right arrow Articles by Christensen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bathum, L.
Right arrow Articles by Christensen, K.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2001;47:81-87.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Evidence for a Substantial Genetic Influence on Biochemical Liver Function Tests: Results from a Population-based Danish Twin Study

Lise Bathum1,a, Hans Christian Petersen2, Jens-Ulrik Rosholm1, Per Hyltoft Petersen1, James Vaupel2,3,4 and Kaare Christensen2,3

1 Department of Clinical Biochemistry, Odense University Hospital, DK-5000 Odense C, Denmark.

2 The Danish Center for Demographic Research and Epidemiology, Institute of Public Health, University of Southern Denmark, Main Campus: Odense University, DK-5000 Odense, Denmark.

3 Terry Sanford Institute, Duke University, Durham, NC 27708-0245.

4 Max Planck Institute for Demographic Research, Rostock D-18057, Germany.
a Address correspondence to this author at: Department of Clinical Biochemistry, Odense University Hospital, DK-5000 Odense C, Denmark. Fax 45-6541-1911; Lise.Bathum{at}ouh.fyns-amt.dk.


   Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Background: Biochemical liver function tests are widely used in the clinic and are some of the most frequently used tests in screening for diseases in older age groups. The aim of the present study was to estimate the relative importance of genetic and environmental factors to variations in these tests among the elderly.

Methods: We conducted a survey among Danish twins, 73–102 years of age, identified in the population-based Danish Twin Registry. Among the 2749 individuals in the study population, an interview was conducted with 79%. From these, a blood sample was collected from 290 same-sex twin pairs, total of 580 subjects, within a 6-month period and analyzed for alanine aminotransferase (ALT), lactate dehydrogenase (LDH), {gamma}-glutamyltransferase (GGT), bilirubin, and albumin. The interview included questions about alcohol consumption and body mass index (BMI; self-calculated height and weight). Heritability (proportion of the population variance attributable to genetic variation) was estimated using structural-equation analyses before and after correction for alcohol consumption and BMI.

Results: Structural-equation analyses revealed a substantial heritability (35–61%) for the four biochemical liver function tests: ALT, GGT, LDH, and bilirubin. The remaining variation could be attributed to individuals’ nonfamilial environments. Adjustment for alcohol consumption and BMI had no influence on the heritability for ALT, GGT, LDH, and bilirubin. For albumin, two models fit equally well before adjustment for alcohol and BMI: a model including additive genetic and nonshared environmental factors (AE), and a model including shared and nonshared environmental factors (CE). After adjustment, the model including shared and nonshared environment was clearly the best fitting model.

Conclusions: For both males and females, the effect of genetic factors on the biochemical liver function tests ALT, GGT, LDH, and bilirubin is substantial and accounts for one-third to two-thirds of the variation among individuals 73–102 years of age. The heritability is equal for males and females and does not change notably after controlling for alcohol consumption and BMI. For albumin, no major impact of genetic factors was found independent of BMI and alcohol consumption. An understanding of the genetic mechanisms underlying biochemical liver function tests among the very old may be of value in the interpretation of these tests in this age group.


   Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
Biochemical liver function tests are some of the most frequently used tests in the clinic. Strictly speaking, the term "liver function test" is inaccurate because enzyme activities reflect dysfunction and are not specific to the liver, whereas bilirubin and protein concentrations are affected by factors such as hemolysis and nutritional state. Alanine aminotransferase (ALT),1 lactate dehydrogenase (LDH), and {gamma}-glutamyltransferase (GGT) indicate the degree of cellular injury that has occurred during the past few hours (1). GGT is believed to be the most suitable of these liver function tests for examining long-standing excessive alcohol consumption, because alcohol induces formation of the enzyme, and for the recognition of cholestasis (2)(3)(4). The albumin concentration indicates the protein synthetic function of the liver, but albumin synthesis decreases very rapidly (in a few days) in persons on a protein-deficient diet (5). Hypoalbuminemia in liver disease indicates that a chronic liver disease is present (1). Bilirubin is one of the most commonly used liver function tests. Bilirubin is a metabolic breakdown product of heme derived from senescent red blood cells. The liver conjugates and excretes bilirubin into the bile (1). Increased concentrations of unconjugated bilirubin have a high predictive value in the diagnosis of many hepatobiliary disorders.

Liver function tests are used for identifying patients with liver disease; in the differential diagnosis of jaundice; in monitoring the severity, course, and response to treatment of disease; and in detecting hepatotoxicity caused by drugs. Findings of transient, asymptomatic increases in liver function test results, particularly transaminase concentrations are common (6)(7). In particular, treatment with many common drugs [e.g., nonsteroidal anti-inflammatory drugs among others (8)] may cause increases in liver enzyme activity in the absence of clinical liver disease. Although these liver function tests have a low sensitivity for detecting liver diseases and the values frequently are temporarily increased, they are among the most frequently used biochemical tests in screening for diseases in older age groups. Abnormal values usually lead the physician to request a repeated evaluation and new testing, which is accompanied by concern on the patient’s part and additional expense. One study showed that 25–30% of asymptomatic workers screened by five liver tests (bilirubin, ALT, LDH, alkaline phosphatase, and aspartate aminotransferase) had serum concentrations exceeding the reference intervals (6).

Alcohol abuse usually is regarded as the most likely cause of increased liver enzyme activity (2). However, increased body mass index (BMI) has also been shown to be positively correlated with increased liver enzyme activity (9)(10). Furthermore, when changes in biochemical liver tests are studied over time, a significant increase has been shown in subjects who gain weight (11).

Hence, several environmental factors that influence biochemical liver tests are known. Numerous genetic defects that influence biochemical liver tests are also known (e.g., Gilbert syndrome, hemochromatosis, and {alpha}1-antitrypsin deficiency). However, the overall impact of genetic factors on the most widely used biochemical liver tests is unknown. Twin studies are among the best methods to identify the effects of genes and environment. We evaluated the extent to which different biochemical liver tests are influenced by genetic and environmental factors, using elderly twins from the Longitudinal Study of Aging Danish Twins (LSADT-97).


   Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The study was based on the Danish Twin Registry, which has been described in detail previously (12). The registry was established in 1954 as the first nationwide twin registry in the world and includes twin pairs born in Denmark between 1870 and 1910 and same-sex pairs born between 1911 and 1930. From this registry, 2172 twins with a median age of 77 years (range, 72–102 years) participated in the 1997 LSADT survey regardless of whether the co-twin was alive. The survey included an extensive face-to-face interview, comprising questions on self-rated health, alcohol consumption, and height and weight. A total of 456 same-sex pairs participated (13). Blood samples (20 mL of EDTA blood) were collected from all same-sex pairs where both members were willing to give a blood sample. Blood was collected from 699 subjects within a 6-month period. A total of 290 same-sex twin pairs donated a blood sample (64% of all 456 participating same-sex pairs). The samples were centrifuged within 12 h at 1000g for 10 min and separated into cells and plasma layers. The samples were put at -80 °C within 2.5 days (usually within the same day). This study was approved by the seven regional Scientific Ethics Committees in Denmark.

BMI was calculated as weight (kg)/height (m2) based on self-reported data. BMI was categorized in three groups: <22, 22–28, and >28 kg/m2. The interview included questions concerning how many beers, glasses of wine, and drinks of strong alcohol the study subjects drank per week. These were summarized in one variable and categorized in three groups: 0, 1–14, and 15+ drinks per week. In the analysis, alcohol consumption and BMI were treated as categorical variables. Of the 290 same-sex twin pairs who donated blood samples, 257 pairs (88.6%) also provided information on both alcohol consumption and BMI for both twins in the pair. The age range for this group was 73–94 years.

laboratory assays
Serum samples for all study subjects were kept frozen at -80 °C. The samples were thawed at room temperature, mixed, and analyzed within the same day. All analytes were analyzed on the Technicon AXON® System (methods nos. SM4-2157C96, SM4-2172A94, SM4-2179A94, SM4-2142F90, and SM4-2131F90). ALT was measured as described by Wroblewski and LaDue (14) in accordance with the 1978 recommendations from the IFCC (15). LDH was measured by a direct colorimetric measurement of the change in oxidation state of NADH occurring by the conversion of pyruvate to lactate (14)(16). Total bilirubin was analyzed by measuring azobilirubin after the addition of accelerators and diazotized sulfanilic acid (17). GGT was measured by the optimized method described by Shaw et al. (18). Albumin was measured by a direct colorimetric procedure using the specific dye bromcresol green (19). As quality control, a multirule Shewhart chart was used (20). Within-assay CVs for the analyses during the period were as follows: 4.7% for ALT, 6.6% for LDH, 3.7% for bilirubin, 4.4% for GGT, and 3.1% for albumin. The reference intervals for the various analytes were as follows: ALT, 10–50 U/L for males and 10–35 U/L for females; LDH, 200–700 U/L for subjects >70 years; bilirubin, <20 µmol/L; GGT, 5–80 U/L for males and 5–50 U/L for females; albumin, 36–46 g/L.

statistical analysis
In humans, two types of twinning occur: monozygotic (MZ) twins share all genetic material; whereas dizygotic (DZ) twins, like ordinary siblings, share, on average, 50% of their genes. In the classical twin study, MZ and DZ intraclass correlations for a trait are compared. A significantly higher correlation in MZ twins indicates that genetic factors contribute to the variation. To estimate the heritability of the biochemical liver function test (i.e., the proportion of the population variance attributable to genetic variation), the twin data were analyzed using structural-equation biometric models (21). The usual assumptions of a classic twin study [no gene-environment interaction or correlation, no assortative mating or epistasis, and that the degree of environmental similarity is equal for MZ and DZ twins (the equal environment assumption)] were made. For a more detailed description of twin methodologies, see Neale and Cardon (22), Plomin et al. (23), and McClearn et al. (24).

It was assumed that the total phenotype variance (V) could be decomposed as:

where A refers to the variance contribution of additive genetic effects, D refers to the variance contribution of genetic effects attributable to dominance (intralocus interaction), C refers to the variance contribution of shared environmental effects (i.e., environmental factors that are shared by twins reared together and are thus a source of similarity), and E refers to the variance contribution of nonshared environmental effects (i.e., environmental factors that are not shared by twins reared together and are thus a source of random variation). This component also includes measurement error, which in this case is the analytical and intraindividual variation in the biochemical liver function tests. Assuming that shared environmental effects contribute equally to the traits of MZ and DZ twins, the expected twin covariances are given by:


Variance components were estimated from the observed twin variances and covariances by the maximum likelihood method using the Mx software (21). To correct for unequal variances between twin 1 and twin 2, data were entered twice and the degrees of freedom adjusted accordingly (25).

Because the distribution of the data was positively skewed, all results from the liver function tests were transformed into symmetric distributions by taking the loge before analysis. Only intact pairs, i.e., pairs where results from the biochemical analysis and information regarding alcohol consumption and BMI were present for both subjects in the pair, were used in the statistical analysis.

The following models were fitted: ACE, ADE, AE, DE, CE, and E. The ACE model contained an additive genetic component, a shared environmental component, and a nonshared environmental component. The ADE model left out the shared environment, assuming that it was too small to contribute to the overall variation, but contained a dominant genetic component. The AE model contained an additive genetic component and a nonshared environmental component. The CE model contained only the shared and nonshared environmental components assuming that genetic factors do not contribute to the variation, and the E model tested whether the differences in variation between the MZ and DZ twin pairs could be explained by purely nonshared environmental factors. The fit of each model was assessed by a goodness-of-fit {chi}2 test that had between 6 (ACE) and 10 (E) degrees of freedom.

The goal in model fitting is to explain the observed data as well as possible with as few parameters as possible. The Akaike Information Criterion (AIC) (26), which equals the {chi}2 value minus twice the degrees of freedom, was used to find the best fitting model. The model with the lowest AIC value reflected a balance between goodness of fit and parsimony.

On the basis of the best fitting model, the final step in our twin analysis was the estimation of the proportion of variance in the biochemical liver function tests attributable to A, D, C, and E.

To test whether there was a sex difference in genetic and environmental factors, models in which parameter estimates were constrained to be equal across sex groups were compared with models in which estimates were allowed to differ among sexes.

All model-fitting analyses were done twice, before and after adjustment for alcohol consumption and BMI. Adjustment for alcohol consumption and BMI was assessed using residuals from sex-wise regression models.


   Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The basic descriptive statistics for the material are shown in Table 1 . For technical reasons, it was not possible to test one individual (MZ male) for GGT and one individual (DZ female) for LDH. Both members of the pairs of these individuals were omitted from statistical analysis. There were no major differences in the results from the biochemical liver function tests between the different sex and zygosity groups. However, GGT and bilirubin concentrations were slightly higher in males than in females, and LDH concentrations were slightly higher in females than in males. The MZ males had lower LDH values than DZ males, but there was no difference in LDH concentrations between MZ and DZ females.


View this table:
[in this window]
[in a new window]
 
Table 1. Basic descriptives for the study.1

In Table 2 , the data from single individuals, not pairs, are stratified by alcohol consumption and BMI. Subjects without data for alcohol consumption or BMI were categorized as missing. Only pairs for whom information on BMI and alcohol consumption was provided for both twins were used in the model fitting. As shown in Table 2 , this did not produce any bias because the biochemical liver function test results from subjects who did not provide this information did not differ from subjects who provided this information. As can also be seen in Table 2 , there was a difference in alcohol consumption and BMI between males and females. The female twins had a tendency toward a lower BMI and lower alcohol consumption compared with the male twins.


View this table:
[in this window]
[in a new window]
 
Table 2. Biochemical liver function tests stratified as a function of alcohol consumption and BMI on all individuals.1

The intraclass correlations are shown in Table 3 . The correlations for BMI were much higher for MZ twins than for DZ twins, indicating a high genetic component in determination of BMI. For females, all MZ intraclass correlations were significantly larger than 0 and consistently exceeded the corresponding DZ correlations, except for albumin. The female twin correlations were higher compared with the male twin correlations except for bilirubin and albumin before adjustment for alcohol/BMI and for bilirubin after adjustment. The intraclass correlations were almost unchanged after the adjustment except for albumin for MZ males.


View this table:
[in this window]
[in a new window]
 
Table 3. Intraclass correlations1 for the total study sample by zygosity and sex before and after adjustment for alcohol consumption and BMI.

Biometrical analyses revealed that for ALT and GGT, a model including dominant genetic factors and nonshared environment was the best fitting model (lowest AIC; Table 4 ). The fit of the full model estimating separate parameters in the two sexes was compared with the fit of a constrained model specifying equality of the genetic and environmental parameters across the two sexes. Thus additive genetic (A) and shared environmental (C) factors were not needed to account for the observed data. For bilirubin and LDH, a model including additive genetic factors and nonshared environmental factors was the best-fitting model. Thus, the dominant genetic (D) and the shared environment (C) factors were not needed to account for the observed data. For albumin, two models fitted equally well before adjustment for alcohol and BMI, the AE and the CE model. After adjustment, the CE model was clearly the best-fitting model. This change from the fit of two models (AE and CE) to the fit of one model (CE) for albumin was the only effect of adjusting for alcohol consumption and BMI. The models indicated that the heritability is the same for the two sexes.


View this table:
[in this window]
[in a new window]
 
Table 4. Parameter estimates for the best-fitting models.1

The analyses revealed a substantial heritability (35–61%) for the four biochemical markers ALT, GGT, bilirubin, and LDH, but a negligible heritability for albumin. This general pattern was unaltered when adjusted for alcohol consumption and BMI.


   Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 
The aim of this study was to estimate the relative importance of genetic and environmental factors on biochemical liver function test results and to test for a sex-based difference. In addition, we wanted to investigate whether correction for differences in alcohol consumption and BMI would influence the results. Our results should be interpreted in the context of the statistical power of this sample. Twin studies do not have a high power, so the actual sizes of A, D, C, and E are estimates. However, our results indicate that there is a substantial genetic component in the variance of the biochemical liver function tests except for albumin.

The adjustment for BMI and alcohol consumption was based entirely on self-reported data. It could be suspected that subjects with a high BMI or alcohol consumption are reluctant to answer questions regarding these issues and that data would therefore be missing. As a consequence, it is possible that these subjects and their co-twins would be left out of the statistical analysis. This nonrandom omission could introduce a bias. However, as seen in Table 2Up , this did not seem to be the case. The results from individuals were stratified in Table 2Up as a function of alcohol consumption and BMI, and the results from individuals with missing information on BMI and alcohol consumption did not deviate from the other groups. Therefore, it seems likely that subjects who did not provide information regarding BMI and alcohol consumption did not differ from the rest of the group.

As seen in Table 2Up , there are large differences in the distribution of BMI and alcohol consumption between males and females. This was accounted for in the statistical analyses by sex-wise regression analysis. The correlation for BMI was considerably higher in MZ twins than in DZ twins for both males and females, indicating a substantial genetic contribution to the variation in BMI. This large genetic component in BMI has been shown in several other studies (27)(28)(29). The correlation for alcohol consumption in MZ females was twice as high as the correlation in DZ females, whereas there was no difference between the correlation in MZ and DZ males. Previous twin studies have shown quite high heritability estimates for alcohol consumption in both sexes (30)(31), and this has been shown for both frequency of consumption and average quantity consumed (31). The heritability estimates in these studies were higher for females than for males, but it is still surprising that there were no major difference in the correlations for MZ and DZ males in our study.

Twin studies are based on the assumption that the degree of intrapair environmental similarity is equal in MZ and DZ pairs. If, in fact, the environmental similarity is greater among MZ twins than among DZ twins, an overestimation of the genetic influence will occur. However, it seems unlikely that shared environmental differences of this type should be of major importance for these twins, of whom the majority separated more than 50 years ago.

The estimate that one-third to two-thirds of the variation in biochemical liver function test results among our study population is attributable to genetic factors could be an underestimation for several reasons. We did not take the interviewed persons’ disease records into consideration, and the blood samples were collected 3–6 months after the interview. In addition, we did not use information regarding medical history in our models. This means that temporary deviations attributable to, e.g., current or recent acute diseases or different medications will introduce additional variability that will tend to decrease twin similarity. Furthermore, any measurement error in the biochemical analysis or interviewer effect on the information regarding BMI or alcohol consumption will also lead to decreased twin similarity.

In conclusion, the effect of genetic factors on the biochemical liver function tests ALT, GGT, LDH, and bilirubin is substantial and accounts for one-third to two-thirds of the variation among individuals 73–94 years of age, and the heritability is equal among males and females. The adjustment for alcohol consumption and BMI does not alter the correlations in this group of healthy, older twins. For albumin, there is no major impact of genetic factors. The biochemical liver function tests are widely used in the screening for diseases in older age groups, and an understanding of the genetic mechanisms underlying these tests may be of value in their interpretation.


   Acknowledgments
 
Supported by US National Institute on Aging Research Grant NIA-PO1-AG08761 and The Institute of Clinical Research, Odense University Hospital. The activities of the Danish Centre for Demographic Research are funded by a grant from the Danish National Research Foundation.


   Footnotes
 
1 Nonstandard abbreviations: ALT, alanine aminotransferase; LDH, lactate dehydrogenase; GGT, {gamma}-glutamyltransferase; BMI, body mass index; MZ, monozygotic; DZ, dizygotic; AIC, Akaike Information Criterion.


   References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
 

  1. Scheig R. Evaluation of tests used to screen patients with liver disorders. Prim Care 1996;23:551-560.[ISI][Medline] [Order article via Infotrieve]
  2. Patel S, O’Gorman P. Serum enzyme levels in alcoholism and drug dependency. J Clin Pathol 1975;28:414-417.[Abstract/Free Full Text]
  3. Schmidt E, Schmidt FW. Enzyme diagnosis of liver diseases. Clin Biochem 1993;26:241-251.[ISI][Medline] [Order article via Infotrieve]
  4. Sharpe PC, McBride R, Archbold GP. Biochemical markers of alcohol abuse. QJM 1996;89:137-144.[Abstract]
  5. Rothschild MA, Oratz M, Schreiber SS. Albumin synthesis. 1. N Engl J Med 1972;286:748-757.
  6. Wright C, Rivera JC, Baetz JH. Liver function testing in a working population: three strategies to reduce false-positive results. J Occup Med 1988;30:693-697.[ISI][Medline] [Order article via Infotrieve]
  7. Jick H. Drug-associated asymptomatic elevations of transaminase in drug safety assessments. Pharmacotherapy 1995;15:23-25.[ISI][Medline] [Order article via Infotrieve]
  8. Garcia Rodriguez LA, Williams R, Derby LE, Dean AD, Jick H. Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med 1994;154:311–6..
  9. Robinson D, Whitehead TP. Effect of body mass and other factors on serum liver enzyme levels in men attending for well population screening. Ann Clin Biochem 1989;26:393-400.
  10. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem 1991;37:720-723.[Abstract/Free Full Text]
  11. Burns CJ, Boswell JM, Olsen GW. Liver enzyme activity and body mass index. J Occup Environ Med 1996;38:1248-1252.[ISI][Medline] [Order article via Infotrieve]
  12. Kyvik KO, Christensen K, Skytthe A, Harvald B, Holm N. The Danish Twin Registry. Dan Med Bull 1996;43:467-470.[ISI][Medline] [Order article via Infotrieve]
  13. Christensen K, Holm NV, McGue M, Corder L, Vaupel JW. A Danish population-based twin study on general health in the elderly. J Aging Health 1999;11:49-64.[Abstract/Free Full Text]
  14. Wroblewski F, LaDue J. Serum glutamic pyruvic transaminase in cardiac and hepatic disease. Proc Soc Exp Biol Med 1956;91:569.
  15. Bergmeyer HU, Hørder M, Moss DW. Provisional recommendations on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 3. Revised IFCC method for aspartate amino transferase [Special Report]. International Federation of Clinical Chemistry. Committee on Standards. Expert Panel on Enzymes. Clin Chem 1978;24:720-721.[Free Full Text]
  16. . Committee on Enzymes. Recommended methods for the determination of four enzymes in blood. The Scandinavian Society for Clinical Chemistry and Clinical Physiology. Scand J Clin Lab Invest 1974;33:291-306.[ISI][Medline] [Order article via Infotrieve]
  17. Novros JS, Koch TR, Knoblock EC. Improved method for accurate quantitation of total and conjugated bilirubin in serum. Clin Chem 1979;25:1891-1899.[Free Full Text]
  18. Shaw LM, Stromme JH, London JL, Theodorsen L. IFCC method for {gamma}-glutamyltransferase [({gamma}-glutamyl)-peptide:amino acid {gamma}-glutamyltransferase, EC 2.3.2.2]. IFCC methods for measurement of enzymes. Part 4. International Federation of Clinical Chemistry, Scientific Committee, Analytical Section, Expert Panel on Enzymes. J Clin Chem Clin Biochem 1983;21:633-646.[ISI][Medline] [Order article via Infotrieve]
  19. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta 1971;31:87-96.[ISI][Medline] [Order article via Infotrieve]
  20. Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 1981;27:493-501.[Free Full Text]
  21. Neale MC. Mx: Statistical Modeling, 3rd ed. [Computer Program]. Richmond, VA: Neale MC, 1998..
  22. Neale MC, Cardon LR. Methodology for genetic studies of twins and families 1992 Kluwer Academic Publishers Boston, MA. .
  23. Plomin R, Owen MJ, McGuffin P. The genetic basis of complex human behaviors [Review]. Science 1994;264:1733-1739.[Abstract/Free Full Text]
  24. McClearn GE, Johansson B, Berg S, Pedersen NL, Ahern F, Petrill SA, Plomin R. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997;276:1560-1563.[Abstract/Free Full Text]
  25. Sham P. Statistics in human genetics 1998 John Wiley & Sons New York. .
  26. Akaike H. Factor analysis and AIC. Psychometrika 1987;52:317-332.[ISI]
  27. Sørensen TIA, Holst C, Stunkard AJ, Skovgaard LT. Correlations of body mass index of adult adoptees and their biological relatives. Int J Obes Relat Metab Disord 1992;16:227-236.[ISI][Medline] [Order article via Infotrieve]
  28. Stunkard AJ, Harris JR, Pedersen NL, McLearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990;322:1483-1487.[Abstract]
  29. Herskind AM, McGue M, Sorensen TI, Harvald B. Sex and age specific assessment of genetic and environmental influence on body mass index in twins. Int J Obes Relat Metab Disord 1996;20:106-113.[ISI][Medline] [Order article via Infotrieve]
  30. Swan GE, Carmelli D, Rosenman RH, Fabsitz RR, Christian JC. Smoking and alcohol consumption in adult male twins: genetic heritability and shared environmental influences. J Subst Abuse 1990;2:39-50.[Medline] [Order article via Infotrieve]
  31. Heath AC, Meyer J, Jardine R, Martin NG. The inheritance of alcohol consumption patterns in a general population twin sample: II. Determinants of consumption frequency and quantity consumed. J Stud Alcohol 1991;52:425-433.[ISI][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
Am J EpidemiolHome page
M. Kimura, J. v. B. Hjelmborg, J. P. Gardner, L. Bathum, M. Brimacombe, X. Lu, L. Christiansen, J. W. Vaupel, A. Aviv, and K. Christensen
Telomere Length and Mortality: A Study of Leukocytes in Elderly Danish Twins
Am. J. Epidemiol., April 1, 2008; 167(7): 799 - 806.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Ichihara, Y. Itoh, C. W. K. Lam, P. M. K. Poon, J.-H. Kim, H. Kyono, N. Chandrawening, D. Muliaty, and Science Committee for the Asian-Pacific Federation
Sources of Variation of Commonly Measured Serum Analytes in 6 Asian Cities and Consideration of Common Reference Intervals
Clin. Chem., February 1, 2008; 54(2): 356 - 365.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. B. Whitfield
Serum {gamma}-Glutamyltransferase and Risk of Disease
Clin. Chem., January 1, 2007; 53(1): 1 - 2.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
J. B. Whitfield, G. Zhu, J. E. Nestler, A. C. Heath, and N. G. Martin
Genetic Covariation between Serum {gamma}-Glutamyltransferase Activity and Cardiovascular Risk Factors
Clin. Chem., September 1, 2002; 48(9): 1426 - 1431.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bathum, L.
Right arrow Articles by Christensen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bathum, L.
Right arrow Articles by Christensen, K.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Proteomics and Protein Markers


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS